Prader-Willi syndrome and the hypothalamus

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 86, Issue 423, 1997, Pages 50-54

  Swaab, D F ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

Growth hormone; Growth hormone releasing hormone; Hypothalamus; Insatiable hunger; Obesity; Oxytocin; Perinatal problems; Prader Willi syndrome

Indexed keywords

GONADORELIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; LUTEINIZING HORMONE; OXYTOCIN; SEX HORMONE; VASOPRESSIN;

APPETITE DISORDER; CONFERENCE PAPER; CRYPTORCHISM; GENITAL MALFORMATION; GROWTH INHIBITION; HUMAN; HYPOTHALAMUS DISEASE; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; NEWBORN DISEASE; OBESITY; PRADER WILLI SYNDROME; PRIORITY JOURNAL; PUBERTY; SHORT STATURE; SOMNOLENCE; THERMOREGULATION; HYPOTHALAMUS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

GONADOTROPIN-RELEASING HORMONE; GROWTH HORMONE-RELEASING HORMONE; HUMANS; HYPOTHALAMUS; PRADER-WILLI SYNDROME;

EID: 0030727691     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Prader A, Labhart A, Willi H. Ein Syndrom von Adipositas, Kleinwuchs, Kryptorchismus und Oligophrenie nach myatonieartigem Zustand im Neugeborenenalter. Schweiz Med Wochenschr 1956;86:1260-1
2. Wannarachue N, Ruvalcaba RHA, Kelley VC. Hypogonadism in Prader-Willi syndrome. Am J Mental Deficiency 1975; 79:592-6
3. Hamilton CR, Scully RE, Kliman B. Hypogonadotropinism in Prader-Willi syndrome. Am J Med 1972;52:322-9
4. Angulo M, Castro-Magana M, Uy J. Pituitary evaluation and growth hormone treatment in Prader-Willi syndrome. J Pediatr Endocrinol 1991;4:167-73
5. Wharton RH, Bresman MJ. Neonatal respiratory depression and delay in diagnosis in Prader-Willi syndrome. Dev Med Child Neurol 1989;31:231-6
6. Oosterbaan HP, Swaab DF. Circulating neurohypophyseal hormones in anencephalic infants. Am J Obstet Gynecol 1987;157:117-19
7. Visser M, Swaab DF. Life span changes in the presence of α-melanocyte-stimulating-hormone-containing cells in the human pituitary. J Dev Physiol 1979;1:161-78
8. Swaab DF, Boer K, Honnebier WJ. The influence of the fetal hypothalamus and pituitary on the onset and course of parturition. In: Knight J, O'Connor M, editors. The fetus and birth. Ciba Foundation Symposium 47. Amsterdam, New York: EIsevier/North-Holland Biomedical Press, 1977:379-400
9. Willnow S, Kiess W, Butenandt O, Dörr HG, Enders A, Strasser-Vogel B, et al. Endocrine disorders in septo-optic dysplasia (De Morsier syndrome) - evaluation and follow up of 18 patients. Eur J Pediatr 1996;155:179-84
10. Honnebier WJ, Swaab DF. The influence of anencephaly upon intrauterine growth of fetus and placenta and upon gestation length. J Obstet Gynaecol Br Cmwlth 1973;80:577-88
11. Buijs RM, De Vries GJ, Van Leeuwen FW, Swaab DF. Vasopressin and oxytocin: distribution and putative functions in the brain. In: Cross BA, Leng GA, editors. The neurohypophysis: structure, function and control. Prog Brain Res 1983;60:115-22
12. Leibowitz SF, Hammer NJ, Chang K. Hypothalamic paraventricular nucleus lesions produce overeating and obesity in the rat. Physiol Behav 1981;27:1031-40
13. Rogers RC, Hermann GE. Oxytocin, oxytocin antagonist, TRH, and hypothalamic paraventricular nucleus stimulation effects on gastric motility. Peptides 1986;8:505-13
14. Benelli A, Bertolini A, Arletti R. Oxytocin-induced inhibition of feeding and drinking: no sexual dimorphism in rats. Neuropeptides 1991;20:57-62
15. Olson BR, Drutarosky MD, Stricker EM, Verbalis JG. Brain oxytocin receptor antagonism blunts the effects of anorexigenic treatments in rats: evidence for central oxytocin inhibition of food intake. Endocrinology 1991;129:785-91
16. Olson BR, Drutarosky MD, Chow MS, Hruby VJ, Stricker EM, Verbalis JG. Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats. Peptides 1991;12:113-18
17. Swaab DF, Purba JS, Hofman MA. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. J Clin Endocrinol Metab 1995;80:573-9
18. Gabreëls BAThF, Swaab DF, Seidah NG, Van Duijnhoven HLP, Martens GJM, Van Leeuwen FW. Differential expression of the neuroendocrine polypeptide 7B2 in hypothalami of Prader-(Labhart)-Willi syndrome patients. Brain Res 1994; 657:281-93
19. Miller L, Angulo M, Price D, Taneja S. MR of the pituitary in patients with Prader-Willi syndrome: size determination and imaging findings. Pediatr Radiol 1996;26:43-7
20. Vela-Bueno A, Kales A, Soldatos CR, Dobladez-Blanco B, Campos-Castello J, Espino-Hurtado P, et al. Sleep in the Prader-Willi syndrome. Clinical and polygraphic findings. Arch Neurol 1984;41:294-6
21. Rubin K, Cassidy SB, Hypogonadism and osteoporosis. In: Greenswag LR, Alexander RC, editors. Management of Prader-Willi syndrome. New York: Springer-Verlag, 1988
22. Clift S, Dahlitz M, Parkes JD. Sleep apnoea in the Prader-Willi syndrome. J Sleep Res 1994;3:121-6
23. Kaplan J, Fredrickson PA, Richardson JW. Sleep and breathing in patients with the Prader-Willi syndrome. Mayo Clin Proc 1991;66:1124-6
24. Angulo M, Castro-Magana M, Mazur B, Canas JA, Vitollo PM, Sarrantonio M. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome. J Pediatr Endocrinol Metab 1996;9:393-400
25. Costof H, Holm VA, Ruvalcaba R, Sharer J. Growth hormone secretion in Prader-Willi syndrome. Acta Paediatr Scand 1990;79:1059-62
26. Cappa M, Grossi A, Borrelli P, Ghigo E, Bellone J, Benedetti S, et al. Growth hormone (GH) response to combined pyridostigmine and GH-releasing hormone administration in patients with Prader-Labhart-Willi syndrome. Horm Res 1993;39:51-5
27. Lee PDK, Wilson DM, Hintz RL, Rosenfeld RG. Growth hormone treatment of short stature in Prader-Willi syndrome. J Pediatr Endocrinol 1987;2:31-4
28. Ciofi P, Tramu G, Bloch B. Comparative immunohistochemical study of the distribution of neuropeptide Y, growth hormone-releasing factor and the carboxyterminus of precursor protein GHRF in the human hypothalamic infundibular area. Neuroendocrinology 1990;51:429-36